Experts from three major organizations add ROS1 to list of tests matching lung cancer with targeted treatments.
30-Jan-2018 11:05 AM EST Add to Favorites
A University of Colorado Cancer Center study published in the journal Pediatric Blood Cancers lays the scientific groundwork for the use of PD-1 inhibitors with an aggressive form of brain cancer, namely supratentorial pediatric ependymoma.
29-Jan-2018 11:05 AM EST Add to Favorites
Patients who developed bloodstream infections had significantly reduced microbiome diversity than patients who remained free of infection.
22-Jan-2018 11:05 AM EST Add to Favorites
Among patients older than 80 years, 3.9 percent receiving surgery passed away within the 30-day post-treatment window, compared with 0.9 percent of patients receiving focused radiation.
19-Jan-2018 8:05 AM EST Add to Favorites
University of Colorado Cancer Center study shows that radiosurgery may effectively treat brain metastases associated with certain types of lung cancer, even when the number of metastases exceeds established norms.
19-Dec-2017 11:05 AM EST Add to Favorites
When a targetable genetic alteration is present, matching the alteration with the appropriate targeted therapy is associated with a survival benefit of 1.5 years, regardless of smoking history.
13-Dec-2017 11:05 AM EST Add to Favorites
Though most “low molecular weight polycyclic aromatic hydrocarbons” (LMW PAHs) have not been shown to cause cancer alone, the study shows that in common combinations, these chemicals can help to spark the disease.
30-Nov-2017 4:10 PM EST Add to Favorites
Many cancers depend on glucose consumption for energy, but good pharmacological targets to stop cancers’ ability to uptake and metabolize glucose are missing. CU Cancer Center study finally identifies a way to restrict the ability of cancer to use...
7-Nov-2017 11:05 AM EST Add to Favorites
see all news
27-Jul-2015 11:05 AM EDT
An education session presented today at the American Society for Clinical Oncology (ASCO) Annual Meeting 2014 details the challenges of collaboration between oncologists and pathologists in the context of molecular testing patient tumor samples.
30-May-2014 4:00 PM EDT